Physician

Eric J. Avery, M.D.

According to 2025 Medicare claims, Eric Avery, M.D. (NPI: 1093934598) practices hematology/oncology in the Lincoln, NE market, with the plurality of this provider's patient population coming from Lancaster, NE. This provider's primary affiliated billing organization is NEBRASKA HEMATOLOGY-ONCOLOGY, PC (NPI: 1205915071; TIN: 911806105) and primary practice location at 68506-7548. Avery is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), Caravan Health ACO 50 LLC (ACO ID: A5160), and Aledade 149 Regional MSSP (ACO ID: A5231), participating under the MSSP model.

Avery's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,001 traditional Medicare patients, billed 355,847 HCPCS/CPT codes, and received $6,493,170 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,563 prescription claims across 251 beneficiaries totaling $4,919,289 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 124 claims. Open Payments data shows 38 records totaling $485,856. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,607,139 to $6,493,170. Similarly, Part D prescription costs have moved sharply higher in recent years, from $638,229 to $4,919,289. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $13,766 to $1,255.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	623	114,215	$1,607,139
2016	606	85,813	$1,296,854
2017	658	156,423	$3,145,834
2018	782	220,111	$4,129,005
2019	750	279,647	$4,692,362
2020	799	236,606	$4,697,233
2021	876	279,199	$5,309,006
2022	964	263,258	$4,533,762
2023	922	278,570	$4,511,071
2024	1,001	355,847	$6,493,170

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	144	824	$638,229
2016	144	909	$883,569
2017	174	1,024	$1,017,820
2018	179	1,131	$1,568,233
2019	209	1,403	$3,302,213
2020	217	1,373	$2,768,583
2021	239	1,326	$2,932,673
2022	236	1,259	$3,738,048
2023	238	1,257	$4,291,628
2024	251	1,563	$4,919,289

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	128	$12,179
2016	N/R	46	$4,265
2017	N/R	31	$9,225
2018	N/R	35	$4,194
2019	11	96	$9,519
2020	25	108	$7,737
2021	N/R	78	$4,503
2022	N/R	43	$4,667
2023	N/R	85	$7,878
2024	N/R	124	$6,028

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	404	574	$61
80053	Blood test, comprehensive group of blood chemicals	695	2,023	$10
36415	Insertion of needle into vein for collection of blood sample	609	1,461	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	721	2,368	$8
83615	Lactate dehydrogenase (enzyme) level	542	1,420	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	36	1,080	$587,132
Venclexta	Venetoclax	53	1,600	$448,617
Lenalidomide	Lenalidomide	40	1,036	$438,313
Revlimid	Lenalidomide	27	742	$384,011
Ibrance	Palbociclib	20	588	$302,470

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	12	$1,461
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	12	$1,308
A4425	Ostomy pouch, drainable; for use on barrier with non-locking flange, with filter (2 piece system), each	N	N/R	12	$863
J8700	Temozolomide, oral, 5 mg	N	N/R	20	$604
J8521	Capecitabine, oral, 500 mg	N	N/R	17	$584

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$776	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$485,080	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eric J. Avery, M.D.?

Tedicare shows public-source Medicare data for Eric J. Avery, M.D. (NPI 1093934598), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric J. Avery, M.D. have ACO affiliation data?

Eric J. Avery, M.D. is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Aledade 149 Regional MSSP (MSSP, ACO ID A5231).

What billing organization is linked to Eric J. Avery, M.D.?

Eric J. Avery, M.D. is linked to NEBRASKA HEMATOLOGY-ONCOLOGY, PC (billing NPI 1205915071) in the available physician profile data.

Does Eric J. Avery, M.D. have Open Payments data?

Eric J. Avery, M.D. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.